CLINICAL_TRIALS
ClinicalTrials.gov record with results posted
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®) in Comparison With OnabotulinumtoxinA (Botox®) When Treating Adults With Upper Limb Spasticity
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04936542
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-07-10T00:09:17.597918+00:00
- Published At
- 2026-07-09T00:00:00+00:00
- Record Updated At
- 2026-07-09
- Results Posted At
- 2026-07-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Upper Limb Spasticity"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-07-09"- protocolSection.identificationModule.nctId
"NCT04936542"- protocolSection.identificationModule.officialTitle
"A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport\u00ae) in Comparison With OnabotulinumtoxinA (Botox\u00ae) When Treating Adults With Upper Limb Spasticity"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-07-09"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.